Stay updated on Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Sign up to get notified when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.

Latest updates to the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check30 days agoChange DetectedThe page has been updated to reflect a shift from a recruiting status to an active status, with new dates for study timelines and a clarification on the sharing of individual participant data.SummaryDifference4%
- Check37 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check44 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has updated the type of intervention and contact information for Liset Chacin, along with a revision update from v2.13.3 to v2.14.0.SummaryDifference0.6%
Stay in the know with updates to Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.